October 28, 2002
NEL HOME, Newsletter
AIM & SCOPE
BOARD OF EDITORS
INSTRUCTIONS
Z.KLEIN AWARD for Human Ethology
NEL SUPPLEMENTS
CONTENTS Vol.23 No.3 June 2002
VOL.22, 2001
VOL.21, 2000
VOL.20, 1999
VOL.19, 1998
VOL.18, 1997
PRESS ROOM
CONTACT
SUBSCRIBE order
Neuroendocrinology Letters incl. Psychoneuroimmunology & Chronobiology

NEUROENDOCRINOLOGY LETTERS
including Psychoneuroimmunology, Neuro
psychopharmacology,
Reproductive Medicine, Chronobiology
and Human Ethology
ISSN 0172–780X

NEL Vol.23 No.3, June 2002

ORIGINAL RESEARCH PAPER

2002; 23:213–217
pii: NEL230302A01
PMID: 12080280

Free full text online
pdf [234kb]

purchace & print HERE


Cellular Localization of a chromogranin B-like derived peptides in leeches

Michel Salzet

Laboratoire de Neuroimmunologie des Annélides,
Université des Sciences et Technologies de Lille.
59650 Villeneuve d'Ascq, FRANCE.

Keywords:
chromogranin B, leech, Immunocytochemistry, Secretolytin


Abstract

Using immunocytochemistry techniques, we demonstrated specific immunostaining with antibodies rose against fragment (547-560) and (614-626) of bovine chromogranin B (CGB) at the level of brain and the tegument of the leech Theromyzon tessulatum. The used of these antibodies on leech sections revealed immunopositive labeling in neurons and glial cells of the central nervous system (CNS), and epidermal glandular cells of the tegument. Co-localization between two antibodies rose against different fragment of bovine CGB have been demonstrated in neurons and glial cells of leech CNS like in vertebrates. Finally, the whole of the data showed for the first time the presence in leeches of CGB like derived peptides.

1. Introduction

Chromogranins are acidic proteins which are found throughout neuroendocrine system [1]. They comprise several defined proteins which have been named chromogranin A [2, 3], chromogranin B [4] [5]; secretogranin II [6] [7], 7B2 [8], ProSAAS [9]. These proteins distribution have been undergone in rat brain in great detail [1, 6, 10-12]. Interestingly, prochromogranin B (CGB) is known to be processed in several peptides i.e. GAWK, CCB, BAM-1745, OA21, OA8, LE-20, NL-10, OY-10 presenting several different biological functions [5]. In addition to their roles as helper proteins in the packaging of peptides, they may serve as pro-hormones to generate biologically active peptides such as vasostatin-1 and secretolytin [13, 14]. These molecules derived from CGA and CGB respectively, possess antimicrobial properties [13, 14]. From the C-terminal part of CGB, two peptides have been identified in both rat and bovine endocrine tissue i.e. the peptide 11 (PE11) at position 552-562 [15] and secretolytin at position 614-621 [13]. We have recently demonstrated that immune cells also contain CGA and CGB [16-18] like proenkephalin [19]. Moreover, secretolytin is shown to be released from monocytes in vitro under interleukin 6 stimulation [20]. In the present study, we demonstrate using the immunocytochemical technique that chromogranin B derived peptides like a leech secretolytin are also present in leeches like we also previously demonstrated for enkelytin, another antimicrobial neuropeptide derived peptide, the proenkephalin [21-23].

... ...

... ...

REFERENCES:

1. Fahrenkamp, A.G., et al., Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract. Virchows Arch, 1995. 426(4): p. 361-7.
2. Blaschko, H., et al., Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulation. Nature, 1967. 215(96): p. 58-9.
3. Blaschko, H., Biochemical studies on chromaffin cells. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol, 1967. 257(1): p. 143-7.
4. Benjannet, S., et al., Chromogranin B (secretogranin I), a putative precursor of two novel pituitary peptides through processing at paired basic residues. FEBS Lett, 1987. 224(1): p. 142-8.
5. Grandy, D.K., et al., Nucleotide and deduced amino acid sequence of bovine adrenal medulla chromogranin B (secretogranin I). Cell Mol Neurobiol, 1992. 12(2): p. 185-92.
6. Schmid, K.W., et al., Chromogranin A, secretogranin II and vasoactive intestinal peptide in phaeochromocytomas and ganglioneuromas. Histopathology, 1993. 22(6): p. 527-33.
7. Overdick, B., et al., Presence and distribution of a new neuropeptide, secretoneurin, in human retina. Peptides, 1996. 17(1): p. 1-4.
8. Day, R., et al., Maintained PC1 and PC2 expression in the AtT-20 variant cell line 6T3 lacking regulated secretion and POMC: restored POMC expression and regulated secretion after cAMP treatment. DNA Cell Biol, 1995. 14(2): p. 175-88.
9. Fricker, L.D., et al., Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing. J Neurosci, 2000. 20(2): p. 639-48.
10. Schmid, K.W., et al., Immunohistochemical localization of chromogranins A and B and secretogranin II in normal, hyperplastic and neoplastic prostate. Histopathology, 1994. 24(3): p. 233-9.
11. Schmid, K.W., et al., Immunohistochemical demonstration of chromogranin A, chromogranin B, and secretogranin II in extra-adrenal paragangliomas. Mod Pathol, 1994. 7(3): p. 347-53.
12. Schmid, K.W., et al., Immunohistochemical comparison of chromogranins A and B and secretogranin II with calcitonin and calcitonin gene-related peptide expression in normal, hyperplastic and neoplastic C-cells of the human thyroid. Histopathology, 1992. 21(3): p. 225-32.
13. Strub, J.M., et al., Antibacterial activity of secretolytin, a chromogranin B-derived peptide (614-626), is correlated with peptide structure. FEBS Lett, 1996. 379(3): p. 273-8.
14. Metz-Boutigue, M.H., et al., Antibacterial peptides are present in chromaffin cell secretory granules. Cell Mol Neurobiol, 1998. 18(2): p. 249-66.
15. Kroesen, S., et al., Rat brain: distribution of immunoreactivity of PE-11, a peptide derived from chromogranin B. Eur J Neurosci, 1996. 8(12): p. 2679-89.
16. Salzet, M., Immune cells express endocrine markers. Neuroendocrinol Lett, 2002. 23(1): p. 8-9.
17. Salzet, M., Neuroimmunology of opioids from invertebrates to human. Neuroendocrinol Lett, 2001. 22(6): p. 467-74.
18. Salzet, M., Vertebrate innate immunity resembles a mosaic of invertebrate immune responses. Trends Immunol, 2001. 22(6): p. 285-8.
19. Tasiemski, A., et al., The presence of antibacterial and opioid peptides in human plasma during coronary artery bypass surgery. J Neuroimmunol, 2000. 109(2): p. 228-35.
20. Taseimki et al., 20002
21. Tasiemski, A., et al., Proenkephalin A-derived peptides in invertebrate innate immune processes. Brain Res Mol Brain Res, 2000. 76(2): p. 237-52.
22. Salzet, M., Neuroimmunology of opioids from invertebrates to human. Neuroendocrinol Lett, 2001. 22(6): p. 467-74.
23. Salzet, M. and A. Tasiemski, Involvement of pro-enkephalin-derived peptides in immunity. Dev Comp Immunol, 2001. 25(3): p. 177-85.
24. Malecha, J., et al., [Evidence of apparent vasopressin and oxytocin peptides in the brain of the leech Rhynchobdelle Theromyzon tessulatum (O.F.M.)]. Gen Comp Endocrinol, 1986. 64(1): p. 13-20.
25. Malecha, J., [Osmoregulation in Hirudinea Rhynchobdellida Theromyzon tessulatum (O.F.M.). Experimental localization of the secretory zone of a regulation factor of water balance]. Gen Comp Endocrinol, 1983. 49(3): p. 344-51.
26. Salzet, M., et al., Oxytocin-like peptide: a novel epitope colocalized with the FMRFamide-like peptide in the supernumerary neurons of the sex segmental ganglia of leeches--morphological and biochemical characterization; putative anti-diuretic function. Brain Res, 1993. 601(1-2): p. 173-84.
27. Kimura, N., et al., Immunohistochemical expression of chromogranins A and B, prohormone convertases 2 and 3, and amidating enzyme in carcinoid tumors and pancreatic endocrine tumors. Mod Pathol, 2000. 13(2): p. 140-6.
28. Stefano, G.B., B. Salzet, and G.L. Fricchione, Enkelytin and opioid peptide association in invertebrates and vertebrates: immune activation and pain. Immunol Today, 1998. 19(6): p. 265-8.

__________________________________________________________
Copyright © Neuroendocrinology Letters 2002
All rights reserved. No part may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or ortherwise, without prior written permission from the Editor-in-Chief.